Anita Z. Graham's most recent trade in Laboratory Corp. Of America Holdings was a trade of 3,200 Non-qualified Stock Options done . Disclosure was reported to the exchange on Feb. 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Labcorp | Anita Z. Graham | EVP, CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 3,200 | 3,200 | - | - | Non-qualified Stock Options | |
| Labcorp | Anita Z. Graham | EVP, CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 1,070 | 2,091 | - | - | Restricted Stock Unit | |
| Labcorp | Anita Z. Graham | EVP, CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 369 | 1,021 | - | - | Restricted Stock Unit | |
| Labcorp | Anita Z. Graham | EVP, CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 369 | 869 (0%) | 0% | - | Common Stock | |
| Labcorp | Anita Z. Graham | EVP, CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 326 | 1,390 | - | - | Restricted Stock Unit | |
| Labcorp | Anita Z. Graham | EVP, CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 326 | 618 (0%) | 0% | - | Common Stock | |
| Labcorp | Anita Z. Graham | EVP, CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 246.27 per share. | 06 Feb 2025 | 119 | 750 (0%) | 0% | 246.3 | 29,306 | Common Stock |
| Labcorp | Anita Z. Graham | EVP, CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 247.74 per share. | 06 Feb 2025 | 118 | 500 (0%) | 0% | 247.7 | 29,233 | Common Stock |
| Labcorp | Anita Z. Graham | EVP, CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 3,000 | 3,000 | - | - | Non-qualified Stock Options | |
| Labcorp | Anita Z. Graham | EVP, CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 980 | 2,085 | - | - | Restricted Stock Unit | |
| Labcorp | Anita Z. Graham | EVP, CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 369 | 399 (0%) | 0% | - | Common Stock | |
| Labcorp | Anita Z. Graham | EVP, CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 369 | 1,716 | - | - | Restricted Stock Unit | |
| Labcorp | Anita Z. Graham | EVP, CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.71 per share. | 06 Feb 2024 | 107 | 292 (0%) | 0% | 223.7 | 23,937 | Common Stock |